Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on Asthma Control
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02189616 |
Recruitment Status : Unknown
Verified August 2014 by songlq, Xijing Hospital.
Recruitment status was: Recruiting
First Posted : July 14, 2014
Last Update Posted : August 19, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Asthma is the disease being studied. The main objective of this study is to assess the clinical efficacy of mobile phone short message service (SMS) reminder and consultation on the self-management and outcomes of poorly controlled asthma which is first diagnosed in a time period of 3 months. The secondary objective is to explore the cost-benefit and cost-effectiveness of the proposed intervention.
Aims: The main aim of this study is to assist asthma patients to practice asthma self-management at home by sending reminders and responding to patients' consultations with mobile phone short message service (SMS), which will eventually help them to control their asthma, and prevent asthma exacerbation. Thus, the ultimate goal of this proposed study is to improve patient health outcome via enhancing patient-physician interaction through mobile phone short message service (SMS) that is low-cost and could be followed easily by the patients and their physicians.
The hypothesis is that asthma patients who receive weekly text message reminders to educate them and reinforce adherence will have better asthma outcome, such as asthma control, while the intervention integrating patient consultation and reminders by SMS improve asthma outcome even more. The investigators further hypothesize that these subjects under intervention will have an improvement in secondary measures including quality of life and patient satisfaction. The investigators also anticipate that such an approach in asthma management will be cost-effective.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Asthma | Behavioral: SMS reminder Other: SMS consultation Other: regular care | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 360 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Evaluate the Clinical Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on the Self-management and Outcomes of Poorly-controlled Asthma: a Multicenter Randomized Controlled Trial |
Study Start Date : | July 2014 |
Estimated Primary Completion Date : | December 2014 |
Estimated Study Completion Date : | December 2014 |
Arm | Intervention/treatment |
---|---|
regular care group
receive regular care which contains filling a paper asthma diary daily.
|
Other: regular care
patients are asked to fill in their paper asthma diary daily for 3 months |
Experimental: SMS reminder group
receive weekly mobile phone short message reminders for 3 months
|
Behavioral: SMS reminder
send weekly mobile phone short message reminders to the intervention group Other: regular care patients are asked to fill in their paper asthma diary daily for 3 months |
Experimental: SMS reminder and SMS consultation group
receive weekly mobile phone short message reminders and can consult asthma nurse by mobile phone short message when needed for 3 months
|
Behavioral: SMS reminder
send weekly mobile phone short message reminders to the intervention group Other: SMS consultation told patients to consult qualified asthma nurses by SMS when they need Other: regular care patients are asked to fill in their paper asthma diary daily for 3 months |
- change in asthma control measured by Asthma Control Test(ACT) [ Time Frame: 3 months ]change in asthma control measured by Asthma Control Test(ACT) between baseline and 3 months after randomization.
- score of knowledge, attitude, and self efficacy asthma questionnaire (KASE-AQ) [ Time Frame: 3 months ]score of knowledge, attitude, and self efficacy asthma questionnaire (KASE-AQ) at baseline and 3 months
- Mini-asthma quality of life questionnaire (mini-AQLQ) [ Time Frame: 3 months ]mini-AQLQ scores at baseline and 3 months after the randomization
- asthma control [ Time Frame: 3 months ]change of asthma control level indicated by symptom score, PEF and asthma exacerbations (asthma hospitalizations, emergency department visits, or oral corticosteroid dispensing) from baseline to the end of intervention(3 months)
- cost effectiveness [ Time Frame: 3 months ]The cost effectiveness of SMS reminder and consultation interventions compared to controls without study interventions.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Physician diagnosed uncontrolled or partly-controlled asthma by Global Initiative for Asthma(GINA) standard.
- At least 6 months asthma history.
- Ownership of a mobile phone and currently using the text messaging service.
- Age between 18 and 65 years old.
- Willingness to participate in this study.
- Willing to sign the written informed consent to take part in the study.
Exclusion Criteria:
- Inability to provide written informed consent or to fill in the paper asthma diary.
- A history of smoking cigarettes for greater than ten pack years.
- Other current or a history of severe comorbidity.
- Being in other clinical trials.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02189616
Contact: Juan Wang, master | 18909233806 | ddys1211@163.com |
China, Shaanxi | |
Xijing Hospital | Recruiting |
Xi'an, Shaanxi, China, 710032 | |
Contact: zhikui li, doctor 13571855922 lizhikui@fmmu.edu.cn | |
Contact: liqiang song, doctor 13991160546 songlq@fmmu.edu.cn | |
Sub-Investigator: Xiaofan Hu, Bachelor | |
Principal Investigator: liqiang song, doctor |
Principal Investigator: | liqiang song, doctor | first affiliated hospital, the fourth military medical university |
Responsible Party: | songlq, vice director of department of respirotary and critical care medine, Xijing Hospital |
ClinicalTrials.gov Identifier: | NCT02189616 |
Other Study ID Numbers: |
xjhx-song2 |
First Posted: | July 14, 2014 Key Record Dates |
Last Update Posted: | August 19, 2014 |
Last Verified: | August 2014 |
asthma management SMS reminder SMS consultation |
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |